220 related articles for article (PubMed ID: 16912487)
1. Non-invasive detection of fetal rhesus D status: a comparison between polymerase chain reaction and flow cytometry.
Di Simone N; Lai M; Rumi C; Riccardi P; D'Asta M; Leone G; Mancuso S; Caruso A
Fetal Diagn Ther; 2006; 21(5):404-9. PubMed ID: 16912487
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
3. Fetal RhD genotyping by analysis of maternal blood. A case report.
Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
[TBL] [Abstract][Full Text] [Related]
4. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of fetal cell sorting to determine prenatally fetal E/e or e/e Rh genotype from peripheral maternal blood.
Geifman-Holtzman O; Makhlouf F; Kaufman L; Gonchoroff NJ; Holtzman EJ
Am J Obstet Gynecol; 2000 Aug; 183(2):462-8. PubMed ID: 10942488
[TBL] [Abstract][Full Text] [Related]
6. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
[TBL] [Abstract][Full Text] [Related]
7. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
[TBL] [Abstract][Full Text] [Related]
8. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
[TBL] [Abstract][Full Text] [Related]
11. Fetal RhD genotyping by maternal serum analysis: a two-year experience.
Gautier E; Benachi A; Giovangrandi Y; Ernault P; Olivi M; Gaillon T; Costa JM
Am J Obstet Gynecol; 2005 Mar; 192(3):666-9. PubMed ID: 15746656
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.
Mohammed N; Kakal F; Somani M; Zafar W
J Coll Physicians Surg Pak; 2010 Apr; 20(4):246-9. PubMed ID: 20392400
[TBL] [Abstract][Full Text] [Related]
13. Prenatal determination of fetal RhD type by DNA amplification.
Bennett PR; Le Van Kim C; Colin Y; Warwick RM; Chérif-Zahar B; Fisk NM; Cartron JP
N Engl J Med; 1993 Aug; 329(9):607-10. PubMed ID: 8341334
[TBL] [Abstract][Full Text] [Related]
14. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers.
Moise KJ; Boring NH; O'Shaughnessy R; Simpson LL; Wolfe HM; Baxter JK; Polzin W; Eddleman KA; Hassan SS; Skupski D; McLennan G; Paladino T; Oeth P; Bombard A
Prenat Diagn; 2013 Jan; 33(1):95-101. PubMed ID: 23225162
[TBL] [Abstract][Full Text] [Related]
16. A multiplex PCR for non-invasive fetal RHD genotyping using cell-free fetal DNA.
Tounta G; Vrettou C; Kolialexi A; Papantoniou N; Destouni A; Tsangaris GT; Antsaklis A; Kanavakis E; Mavrou A
In Vivo; 2011; 25(3):411-7. PubMed ID: 21576416
[TBL] [Abstract][Full Text] [Related]
17. Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation.
Akolekar R; Finning K; Kuppusamy R; Daniels G; Nicolaides KH
Fetal Diagn Ther; 2011; 29(4):301-6. PubMed ID: 21212654
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive antenatal RHD typing.
Van der Schoot CE; Soussan AA; Koelewijn J; Bonsel G; Paget-Christiaens LG; de Haas M
Transfus Clin Biol; 2006; 13(1-2):53-7. PubMed ID: 16564727
[TBL] [Abstract][Full Text] [Related]
20. Prenatal determination of the fetal RhD blood group by multiplex PCR: a 7-year Portuguese experience.
Pereira JC; Couceiro AB; Cunha EM; Machado AI; Tamagnini GP; Martins NP; Ribeiro ML
Prenat Diagn; 2007 Jul; 27(7):633-7. PubMed ID: 17497744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
